American Doctor with Ebola Evacuated to Germany for Care

An American surgeon who contracted Ebola while operating on a patient in the Democratic Republic of Congo has been evacuated to Charité hospital in Berlin, Germany, for specialized treatment. The case has spotlighted the rapid escalation of a rare strain of Ebola that has now infected nearly 600 people across Central Africa.

Dr. Peter Stafford, 39, a board-certified general surgeon working with the Christian missionary organization Serge, unknowingly operated on a 33-year-old patient at Nyankunde Hospital in Bunia, Ituri Province, who was later found to have died from the virus. According to NBC News, Stafford developed chills, fever, muscle aches, fatigue, and nausea over the weekend and tested positive for Ebola on Sunday, May 17.

A Perilous Evacuation

By the time Stafford was flown to Germany on Tuesday, he was “barely able to stand on his own,” according to Dr. Scott Myhre, East and Central Africa area director for Serge. Myhre described the scene to NBC News: “There were people in full — we call it PPE — the personal protective equipment, and they’re completely covered, and he’s hanging on them barely strong enough to walk. He looked really tired and really sick.”

Stafford was placed in a tube-shaped plastic bed “about the size of a casket” to protect the flight crew from infection. He is now receiving care at Charité hospital in Berlin, one of Europe’s premier infectious disease treatment centers.

Family and Colleagues Under Monitoring

Stafford’s wife, Dr. Rebekah Stafford, 38, an OB/GYN who also treated the same patient, has traveled to Germany with their four young children. They remain asymptomatic and are being monitored. A third Serge physician, Dr. Patrick LaRochelle, 46, who was potentially exposed through a second patient, has been evacuated to Bulovka Hospital in Prague, the BBC reported.

Matt Allison, Executive Director of Serge, told CBS News that Stafford is “doing well, all things considered. He’s sick. He’s sad to be away from his family, but he’s getting the best care available to him.” The CDC is working to evacuate at least six other Americans who were exposed to the virus.

A Rare and Dangerous Strain

The outbreak involves the Bundibugyo ebolavirus (BDBV), a rare strain first discovered in Uganda in 2007. Unlike the more common Zaire strain — for which the Ervebo vaccine exists — there is no approved vaccine or specific therapeutics for Bundibugyo. According to the World Health Organization, previous Bundibugyo outbreaks have carried a case fatality rate of 30% to 50%.

This is only the third known outbreak of the Bundibugyo strain and the 17th Ebola outbreak in the DRC since 1976. The WHO declared the outbreak a Public Health Emergency of International Concern (PHEIC) on May 16.

Escalating Crisis in Central Africa

As of May 20, the WHO reported nearly 600 suspected cases and 139 suspected deaths across the DRC and Uganda. WHO Director-General Dr. Tedros Adhanom Ghebreyesus warned that numbers are expected to rise, telling reporters that “given the amount of time the virus was circulating before the outbreak was detected,” the situation will likely worsen, as UN News reported.

The outbreak is centered in Ituri Province, a mineral-rich region plagued by decades of armed conflict, including ongoing violence by the M23 rebel group. Over 2 million people are internally displaced in Ituri and North Kivu provinces, complicating surveillance and containment efforts. A critical four-week detection gap existed between the onset of symptoms in the first known case (April 25) and laboratory confirmation (May 14), suggesting the virus spread significantly before it was identified.

Political Dimensions

U.S. Secretary of State Marco Rubio criticized the WHO for being “a little late to identify this thing unfortunately,” while committing $14 million in U.S. assistance. However, experts pushed back. Gigi Gronvall, an immunologist at Johns Hopkins Bloomberg School of Public Health, told The Guardian that “blaming the WHO is misplaced, because they are operating with limited resources in a difficult setting with many security challenges.”

The U.S. CDC invoked Title 42 on May 18, imposing a 30-day travel ban on foreign passport holders from DRC, Uganda, and South Sudan — the first use of the provision since the COVID-19 pandemic. The WHO advises against such travel restrictions, arguing they push movement to unmonitored crossings and damage local economies.

What to Watch

With no vaccine or specific treatment available for the Bundibugyo strain, the response relies entirely on supportive care, isolation, contact tracing, and safe burials. The combination of a remote conflict zone, a highly mobile population, and a four-week detection gap makes containment particularly challenging. Health experts are watching closely to see whether the international community can mount an effective response amid reduced U.S. public health capacity and ongoing tensions between Washington and the WHO.